Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02617849
Title Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wilson Miller
Indications

melanoma

Therapies

Carboplatin + Paclitaxel + Pembrolizumab

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.